Imeik Technology Development Co.,Ltd.
300896
Ранг среди акций
#3826
Imeik Technology Development Co.,Ltd. specializes in the research, development,... Imeik Technology Development Co.,Ltd. specializes in the research, development, manufacturing, and distribution of biomedical materials. The company's diverse product portfolio caters to both the medical aesthetics field and general skincare needs. Within its medical beauty offerings, Imeik provides a range of recognized brands including Moisten Angel, IFRESH, Yimei, Hearty, Bonita Bonita, and Tightly. Additionally, its comprehensive skincare line features hydrating lotions, anti-aging and firming serums, concentrated essence creams, revitalizing facial masks, restorative chitosan B5 sprays, and clarifying and illuminating liquids. Established in 2004, the company's operations are based in Beijing, China.
Цена акции
$14.33
Рыночная капитализация
$4.34B
Изменение (1 день)
3.76%
Изменение (1 год)
-38.92%
Страна
CN
Торговля Imeik Technology Development Co.,Ltd. (300896)
Категория
Healthcare
EPS для Imeik Technology Development Co.,Ltd. (300896)
EPS по состоянию на June 2026 TTM: $0.53
Согласно последним финансовым отчетам и цене акций Imeik Technology Development Co.,Ltd., текущий EPS компании (TTM) составляет $0.53. В конце 2023 EPS компании составлял $0.87, больше, чем показателю 2022 года, равному $0.60.
История EPS компании Imeik Technology Development Co.,Ltd. с 2014 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| 2026 (TTM) | $0.53 | -40.73% |
| 2024 | $0.89 | 2.66% |
| 2023 | $0.87 | 43.49% |
| 2022 | $0.60 | 21.58% |
| 2021 | $0.50 | 60.03% |
| 2020 | $0.31 | 60.24% |
| 2019 | $0.19 | 75.48% |
| 2018 | $0.11 | 40.94% |
| 2017 | $0.08 | 60.00% |
| 2016 | $0.05 | 189.94% |
| 2015 | $0.02 | -41.92% |
| 2014 | $0.03 | 0.00% |
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| $8.85 | 1,577.73% |
US
|
|
| $6.41 | 1,114.26% |
FR
|
|
| - | - |
JP
|
|
| $3.32 | 529.38% |
US
|
|
| - | - |
CH
|
